In Vivo

SJR Rank #11,095H-index: 77SJR: 0.536Best quartile: Q2
Journal website: aims, scope and author guidelines
Publisher

International Institute of Anticancer Research

Country

Greece

Type

journal

SJR by Edition

2022202500.150.30.450.6

Subject Categories

  • Biochemistry, Genetics and Molecular Biology (miscellaneous)Q2
  • Medicine (miscellaneous)Q2
  • PharmacologyQ3
  • Cancer ResearchQ4

Areas: Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Inflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersGastric Cancer Management and OutcomesHead and Neck Cancer StudiesHepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Surgical TreatmentsNutrition and Health in AgingEsophageal Cancer Research and TreatmentBreast Cancer Treatment StudiesAdvanced Radiotherapy Techniques

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03006009001200

Documents per Year

20222025095190285380

Detailed Information

ISSN

1791-7549, 0258-851X

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

1.94

References per Document

34.73

Coverage

1987-2026

Scope

IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management. The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.

Metrics from SCImago Journal Rank 2025. View on SCImago